場次資訊
09/23臺北醫學大學場次
09/24高雄醫學大學場次
【日期&時間】
[臺北醫學大學場次]
2025年9月23日 (二) 10:00-11:00 醫學綜合大樓後棟16樓 胡水旺國際會議廳
[高雄醫學大學場次]報名連結
2025年9月24日 (三) 10:00-11:00 勵學大樓4F第四會議室
【研討會簡介】
Next-generation sequencing (NGS) has revolutionized cancer research, enabling deeper insights into tumor biology, clonal evolution, and therapeutic resistance. However, the complexity of cancer samples—often degraded, limited in quantity, or highly heterogeneous—poses significant challenges to accurate genomic profiling. In this presentation, we showcase how xGen™ NGS solutions empower researchers to overcome these obstacles, delivering robust performance across a wide range of sample types and variant detection needs.
We highlight the integration of optimized library preparation chemistries and hybridization capture technologies workflows that enable sensitive and specific detection of low-frequency somatic variants, even in FFPE and liquid biopsy samples, which further accelerating biomarker discovery, early cancer detection and innovative MRD research.
By combining high-quality data output with streamlined workflows, xGen™ NGS solutions provide a powerful toolkit for cancer researchers seeking to push the boundaries of precision oncology.
xGen™ NGS Solutions for Cancer Research – Summary
NGS in oncology:
Enables deep understanding of tumor biology, clonal evolution, and therapy resistance.
Challenges:
Cancer samples are often degraded, scarce, and heterogeneous, complicating accurate genomic profiling.
xGen™ solutions:
Optimized library prep and hybridization capture workflows.
Robust performance across diverse sample types, including FFPE and liquid biopsy.
High sensitivity and specificity for detecting low-frequency somatic variants.
Applications:
Accelerates biomarker discovery, early cancer detection, and MRD (minimal residual disease) research.
Advantages:
Combines high-quality data output with streamlined workflows, offering a strong toolkit for advancing precision oncology.
xGen™ NGS 解決方案於癌症研究的應用
1. NGS 在腫瘤學的重要性：可深入解析腫瘤生物學、細胞演化與治療抵抗。
2. 主要挑戰：癌症檢體常具降解、總量少及異質性高的特性，造成分析的難度。
3. xGen™ 解決方案：
整合最佳化的建庫策略與探針捕獲流程。
適用於多樣檢體類型，包括 FFPE與液態活檢 (liquid biopsy)。
高靈敏度與專一性，可偵測低頻體細胞突變。
4. 應用領域：加速 生物標誌物發現、早期癌症檢測與微小殘留病灶 (MRD) 研究。
5. xGen™ 核心優勢：兼具高品質數據與簡化流程，是推動精準腫瘤學的強大工具。
【講者】
陳欽銘 Qinming Chen (Ms) Ph.D
Field Application Scientist, Gene Reading, SEA
Integrated DNA Technologies Pte. Ltd.
